secwatch.observer — SEC 8-K summary
======================================

Issuer:     HOOKIPA Pharma Inc. (HOOK)
CIK:        0001760542
Form:       8-K
Filed at:   2024-07-26T23:59:59+00:00
Accession:  0001104659-24-083019
Event type: leadership
Sentiment:  neutral
Materiality: 0.85
Item codes: 5.02, 7.01, 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HOOKIPA Pharma appoints Dr. Malte Peters CEO and Terry Coelho CFO; launches strategic review for HB-200
--------------------------------------------------------------------------------

- Dr. Malte Peters appointed CEO & President effective July 22, 2024; salary $630k, RSU award $700k.
- Terry Coelho appointed EVP & CFO effective July 22, 2024; salary $480k, signing bonus $240k, RSU $450k.
- Former CEO Jörn Aldag and CFO Reinhard Kandera separated July 22, resigned from board July 23.
- Sean Cassidy appointed independent director and Audit Committee chair effective July 22.
- Company launches strategic review to focus on HB-200 and create shareholder value; no impact on operations or trials.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1760542/000110465924083019/0001104659-24-083019-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1760542/000110465924083019/tm2420181d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-083019

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer